We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Multiplex Assay Optimized for Sexually Transmitted Bacteria

By LabMedica International staff writers
Posted on 15 Dec 2011
A relatively new isothermal nucleic acid-amplification technology has been developed to detect the most insidious of all sexually transmitted diseases of bacterial etiology.

Thermophilic helicase dependent amplification (tHDA) employs helicase to unwind double-stranded DNA at constant temperature, has now been optimized to detect Chlamydia trachomatis and Neisseria gonorrhoeae. More...


Scientists at the Research and Development department at QIAGEN Inc., (Gaithersburg, MD, USA) combined tHDA with sequence-specific sample preparation on magnetic beads and homogeneous endpoint fluorescence detection using dual-labeled probes. This four-plex tHDA assay was applied to the detection of two genes on C. trachomatis and a multicopy gene on N. gonorrhoeae in the presence of an internal control.

Gene targets for multiplex tHDA assay included C. trachomatis genomic DNA olfactory marker protein (omp) gene, C. trachomatis cryptic plasmid gene, and NG multicopy opacity protein (opa) gene. Several different strand displacement polymerases were evaluated during the tHDA assay optimization. The assay showed high analytical sensitivity and specificity of simultaneous detection of both bacteria and is compatible with a wide variety of sample types and media.

The performance of a tHDA system may be further improved as tHDA technology currently has some limitations. Nonspecific amplification and primer-dimer formation are more pronounced in tHDA than in polymerase chain reaction (PCR), making multiplexing with the tHDA system more challenging. Nonspecific amplification of tHDA products tends to occur during tHDA reaction setup at room temperature.

The isothermal reaction conditions and homogeneous endpoint detection utilized in the assay were well suited for laboratory automation and high-throughput screening applications as well as for point-of-care testing. The system is still under development but has already proved that the multiplex isothermal amplification assay with endpoint fluorescent detection is a simple and economic alternative to the real-time PCR. The study was published in the December 2011 edition of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:
QIAGEN Inc.


Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.